Yague E - Search Results

1

Structural insight into the TRIAP1/PRELI-like domain family of mitochondrial phospholipid transfer complexes.

Miliara X, Garnett JA, Tatsuta T, Abid Ali F, Baldie H, Pérez-Dorado I, Simpson P, Yague E, Langer T, Matthews S. Miliara X, et al. Among authors: yague e. EMBO Rep. 2015 Jul;16(7):824-35. doi: 10.15252/embr.201540229. Epub 2015 Jun 12. EMBO Rep. 2015. PMID: 26071602 Free PMC article.

2

Apoptosis inhibitor TRIAP1 is a novel effector of drug resistance.

Adams C, Cazzanelli G, Rasul S, Hitchinson B, Hu Y, Coombes RC, Raguz S, Yagüe E. Adams C, et al. Among authors: yague e. Oncol Rep. 2015 Jul;34(1):415-22. doi: 10.3892/or.2015.3988. Epub 2015 May 19. Oncol Rep. 2015. PMID: 25998939 Free article.

3

MiR-106b~25 cluster regulates multidrug resistance in an ABC transporter-independent manner via downregulation of EP300.

Hu Y, Li K, Asaduzzaman M, Cuella R, Shi H, Raguz S, Coombes RC, Zhou Y, Yagüe E. Hu Y, et al. Among authors: yague e. Oncol Rep. 2016 Feb;35(2):1170-8. doi: 10.3892/or.2015.4412. Epub 2015 Nov 12. Oncol Rep. 2016. PMID: 26573761 Free article.

4

mRNA escape from stress granule sequestration is dictated by localization to the endoplasmic reticulum.

Unsworth H, Raguz S, Edwards HJ, Higgins CF, Yagüe E. Unsworth H, et al. Among authors: yague e. FASEB J. 2010 Sep;24(9):3370-80. doi: 10.1096/fj.09-151142. Epub 2010 May 7. FASEB J. 2010. PMID: 20453113 Free article.

5

Drug resistance in cancer.

Yagüe E, Raguz S. Yagüe E, et al. Br J Cancer. 2005 Oct 31;93(9):973-6. doi: 10.1038/sj.bjc.6602821. Br J Cancer. 2005. PMID: 16234820 Free PMC article.

6

Resistance to chemotherapy: new treatments and novel insights into an old problem.

Raguz S, Yagüe E. Raguz S, et al. Among authors: yague e. Br J Cancer. 2008 Aug 5;99(3):387-91. doi: 10.1038/sj.bjc.6604510. Br J Cancer. 2008. PMID: 18665178 Free PMC article. Review.

7

Activation of the MDR1 upstream promoter in breast carcinoma as a surrogate for metastatic invasion.

Raguz S, Tamburo De Bella M, Tripuraneni G, Slade MJ, Higgins CF, Coombes RC, Yagüe E. Raguz S, et al. Among authors: yague e. Clin Cancer Res. 2004 Apr 15;10(8):2776-83. doi: 10.1158/1078-0432.ccr-03-0517. Clin Cancer Res. 2004. PMID: 15102684

8

Expression of RPIP9 (Rap2 interacting protein 9) is activated in breast carcinoma and correlates with a poor prognosis.

Raguz S, De Bella MT, Slade MJ, Higgins CF, Coombes RC, Yagüe E. Raguz S, et al. Among authors: yague e. Int J Cancer. 2005 Dec 20;117(6):934-41. doi: 10.1002/ijc.21252. Int J Cancer. 2005. PMID: 15986426 Free article.

9

Biological and clinical implications of nicastrin expression in invasive breast cancer.

Filipović A, Gronau JH, Green AR, Wang J, Vallath S, Shao D, Rasul S, Ellis IO, Yagüe E, Sturge J, Coombes RC. Filipović A, et al. Among authors: yague e. Breast Cancer Res Treat. 2011 Jan;125(1):43-53. doi: 10.1007/s10549-010-0823-1. Epub 2010 Mar 12. Breast Cancer Res Treat. 2011. PMID: 20224929

10

Escape from stress granule sequestration: another way to drug resistance?

Yagüe E, Raguz S. Yagüe E, et al. Biochem Soc Trans. 2010 Dec;38(6):1537-42. doi: 10.1042/BST0381537. Biochem Soc Trans. 2010. PMID: 21118122 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page